StreetInsider.com
  • Log-In
  • |
  • Home
  • |
  • E-mail Alerts
  • |
  • My Headlines
  • |
  • Portfolio


  • Home
  • Menu
    • JOIN
    • SI Premium
    • Ratings
    • Mergers
    • Earnings
    • Dividends
    • IPOs
    • Hedge Funds
    • Premium Letters
    • Send a Tip
    • API/Data
  • JOIN
  • SI Premium
    • Full Feed View
    • Headline View
    • SI Premium Squawk Box
    • Alerts
    • Custom Headlines
    • Upgrade Your Current Account
    • API
  • Calendars
    • Co. NDR/Event Calendar
    • Dividend Calendar
    • Earnings Calendar
    • Event Driven
    • FDA Calendar
    • Investor Conferences
    • IPO Calendar
    • Merger Arb
    • Ratings Calendar
    • Stock Split Calendar
  • Ratings
    • Analyst Comments
    • Hot Analyst Comments
    • Analyst EPS Change
    • Analyst EPS View
    • Analyst PT Change
    • Credit Ratings
    • Downgrade News
    • Hot Downgrades
    • New Coverage News
    • Hot New Coverage
    • Upgrade News
    • Hot Upgrades
    • More...
  • Mergers
    • Merger News
    • Hot M&A News
    • Private Equity
    • Rumors
    • SPAC News
    • Spinoffs
    • Merger Arbitrage
    • Event Driven
    • 2021 Top M&A Deals
    • Top 50 Takeover Targets
    • More...
  • Earnings
    • Earnings Calendar
    • Earnings News
    • Hot Earnings
    • Guidance
    • Hot Guidance
    • Conference Calls
    • Earnings History Search
    • More...
  • Dividends
    • Dividend Calendar
    • Dividend News
    • Hot Dividends
    • Dividend Hike
    • Special Dividends
    • Stock Buybacks
    • Hot Stock Buybacks
    • Stock Splits
    • More...
  • IPOs
    • IPO News
    • Hot IPOs
    • Equity Offerings
    • Recent IPOs
    • Upcoming IPOs
    • 2021 Top IPOs
    • More...
  • Hedge Funds
    • 13D
    • 13F
    • 13G
    • Hedge Funds News
    • Hot Insider Trades
    • Insider Trades
    • More...
  • Premium Letters
    • Pulse Picks
    • Stealth Growth Insider
  • Send a Tip
  • API/Data
  • QUICK LINKS :
  • Goldman Sachs Conviction Buy List
  • Warren Buffett News
  • Elliott Management News
  • Follow @Street_Insider

Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh

Article Related SEC Filings (1) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. DGX
10. IONQ

Top News Most Read Special Reports
  • Nasdaq reaches record high close, AI stocks rally
  • Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
  • Exclusive: SB Energy Nasdaq IPO moving forward as planned
  • AI and earnings keep driving markets as focus shifts to Trump-Xi summit
  • Meta bull case increasingly playing out, Mizuho says
  • On Holding sets 2029 financial targets, authorizes $1B share buyback
  • Nasdaq reaches record high close, AI stocks rally
  • Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
  • After-Hours Movers: KBH, WOR, IONQ, TLSI, INNV
  • On Holding sets 2029 financial targets, authorizes $1B share buyback
  • After-Hours Movers: GNRC, FLNC, LEN
  • After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
  • After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
Go back to Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh

Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30

August 10, 2020 3:48 PM EDT
Exhibit 10.1

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF... More

 
Free News Feed
Get our RSS Feed!
© Copyright 2026 StreetInsider.com
Home
Member's Home
Premium Content
Links
Entities
About StreetInsider
Get Our Content
Advertise with Us
Contact Us
Disclaimer
Privacy Policy
Do Not Sell My Information